Logo image of EOSI.PA

EOS IMAGING (EOSI.PA) Stock Fundamental Analysis

EPA:EOSI - Euronext Paris - Matif - FR0011191766

2.45  0 (0%)

Fundamental Rating

1

Overall EOSI gets a fundamental rating of 1 out of 10. We evaluated EOSI against 59 industry peers in the Health Care Equipment & Supplies industry. EOSI has a bad profitability rating. Also its financial health evaluation is rather negative. EOSI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EOSI had negative earnings in the past year.
EOSI.PA Yearly Net Income VS EBIT VS OCF VS FCFEOSI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 -5M -10M -15M

1.2 Ratios

Industry RankSector Rank
ROA -20.29%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EOSI.PA Yearly ROA, ROE, ROICEOSI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 -500 -1K -1.5K -2K -2.5K

1.3 Margins

Industry RankSector Rank
OM -40.25%
PM (TTM) -46.91%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EOSI.PA Yearly Profit, Operating, Gross MarginsEOSI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 50 -50

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, EOSI has more shares outstanding
Compared to 1 year ago, EOSI has a worse debt to assets ratio.
EOSI.PA Yearly Shares OutstandingEOSI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 5M 10M 15M 20M 25M
EOSI.PA Yearly Total Debt VS Total AssetsEOSI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 0.68, we must say that EOSI is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 66.63 is on the high side and indicates that EOSI has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 66.63
Debt/FCF N/A
Altman-Z 0.68
ROIC/WACCN/A
WACCN/A
EOSI.PA Yearly LT Debt VS Equity VS FCFEOSI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 10M -10M 20M

2.3 Liquidity

EOSI has a Current Ratio of 1.37. This is a normal value and indicates that EOSI is financially healthy and should not expect problems in meeting its short term obligations.
EOSI has a Quick Ratio of 1.37. This is a bad value and indicates that EOSI is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.87
EOSI.PA Yearly Current Assets VS Current LiabilitesEOSI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.01% over the past year.
Looking at the last year, EOSI shows a quite strong growth in Revenue. The Revenue has grown by 18.63% in the last year.
EOSI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.78% yearly.
EPS 1Y (TTM)40.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.51%
Revenue 1Y (TTM)18.63%
Revenue growth 3Y-13.71%
Revenue growth 5Y1.78%
Sales Q2Q%-0.28%

3.2 Future

EOSI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 106.76% yearly.
EOSI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.51% yearly.
EPS Next Y42.68%
EPS Next 2Y51.21%
EPS Next 3Y180.42%
EPS Next 5Y106.76%
Revenue Next Year69.87%
Revenue Next 2Y45.9%
Revenue Next 3Y45.27%
Revenue Next 5Y40.51%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EOSI.PA Yearly Revenue VS EstimatesEOSI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
EOSI.PA Yearly EPS VS EstimatesEOSI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

EOSI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EOSI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EOSI.PA Price Earnings VS Forward Price EarningsEOSI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -10.78
EOSI.PA Per share dataEOSI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as EOSI's earnings are expected to grow with 180.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.21%
EPS Next 3Y180.42%

More info and screens

0

5. Dividend

5.1 Amount

EOSI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EOS IMAGING

EPA:EOSI (6/2/2021, 7:00:00 PM)

2.45

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap55.58M
Analysts85
Price Target2.53 (3.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.33
P/FCF N/A
P/OCF N/A
P/B 133.59
P/tB N/A
EV/EBITDA -10.78
EPS(TTM)-0.42
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.05
BVpS0.02
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.29%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -40.25%
PM (TTM) -46.91%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 66.63
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 0.87
Altman-Z 0.68
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.51%
EPS Next Y42.68%
EPS Next 2Y51.21%
EPS Next 3Y180.42%
EPS Next 5Y106.76%
Revenue 1Y (TTM)18.63%
Revenue growth 3Y-13.71%
Revenue growth 5Y1.78%
Sales Q2Q%-0.28%
Revenue Next Year69.87%
Revenue Next 2Y45.9%
Revenue Next 3Y45.27%
Revenue Next 5Y40.51%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A